Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, Dan Rohinton commented about whether V, TSM, MSFT, CP.TO, INTC, FFH.TO, KXS.TO, SHOP.TO, CNQ.TO, BEP.UN.TO, GSY.TO, DOL.TO, DHR, GEV, AMZN, NKE, NVO, TD.TO, MU, FSV.TO, LVMUY, CVE.TO, PPL.TO are stocks to buy or sell.

COMMENT
Markets.

Best way to look ahead from where we are today is to consider which data points are going to filter through for a prolonged period. So, looking at where inflation could be and where interest rates could go over time. Those things will endure longer than any headline events that could resolve quickly.

The oil shock can be temporary, but the lasting effect in terms of inflation is where you want to keep a closer eye.

COMMENT
Volatility creates pockets of opportunity.

When you see the market selling off as a whole, there are a lot of stocks out there where that doesn't make sense.

Today's environment gets him more than a little interested in blue-chip companies that deserve higher valuations and have more durable growth rates than the market is giving them credit for today.

COMMENT
Sectors and companies.

The companies that deserve attention are ones that we're all familiar with. This environment is unique in that some of the bigger-cap stocks (MSFT, META, GOOG, AMZN) are phenomenally well-positioned for where AI's going, as well as for their general defensibility. These names are trading at pretty big discounts relative to their own history.

You can pick up low-debt, high-growth companies at pretty attractive valuations. So big tech as a whole is interesting, with specifics determining which names to actually buy.

COMMENT
Stock selection matters more than ever.

When you look across the different sets of companies, the bottlenecks tend to move.

AI is the biggest cross-sectional theme we're seeing across the entire market. But where you look under the hood step-by-step, and how that value capture changes, is a lot more important than it used to be.

Here's a simple example. All the excitement has been on memory stocks. But NVDA has seen a lot of relative de-rating, trading at huge discount. The pendulum swinging from where you are in the bottleneck, and all the way back to the core bundler, is an example of what you're seeing in the stock market as a whole.

PARTIAL BUY

Well managed, decent distribution. Attractive opportunity today, but you have to have the medium-term view that the oil-price shock will be persistent. He's a buyer, but you have to be careful. Average in over time.

PARTIAL BUY

Higher risk profile. Has come a long way in how assets are managed. An opportunity today if you believe energy prices will remain strong for a prolonged time. Be a bit careful. Dollar-cost average carefully.

CNQ tends to be his go-to producer in the Canadian energy patch.

PARTIAL BUY

He's still a buyer today. De-rated quite a bit. Less discretionary $$ to go around these days. A buying opportunity, average in over time. Its brands are everlasting and iconic, with pricing power over time.

WEAK BUY
Cost base of $220.

Does property management really well, expanding in US. Good company/bad stock. Valuation has been quite high, still at a modest premium. If you're a long-term investor, he wouldn't stop you from averaging in slowly and continuously. He'd lean more Buy than Sell today.

WATCH

Stock's done extremely well. Now let's zoom out a bit. There's a current shift in where profit pools are. Memory has done REALLY well because there's a huge shortage. 

Not a long-term hold. It's known as a "deep cyclical" -- times you make $100 per share, and times you lose $$. This memory shortage is more structural in nature, so at $330 it's worth holding on to. Hold for years 1 and 2 of profitability, but in year 3 market will be anticipating year 4 of potentially negative earnings.

HOLD

If you've held for years, no reason to sell today. He's not a buyer here, mostly fully priced. Fears of US growth are largely behind them. Real questions involve Canadian consumer and whether housing market comes back to life (engine of growth and profitability).

RISKY

Weight-loss drug was a huge launch for it, yet LLY has been surpassing them on clinical trials and pipeline in the therapeutic area. Drug launch does not equal pipeline. NVO is behind, hence the 10x PE. If you buy, you're signing up for the dividend yield and the hope that it doesn't lose too much market share along the way.

Screaming buy? No. Touchstone, cornerstone, foundation? Absolutely not. Makes sense as a very small part of a broad, diversified portfolio? OK.

TRADE

Don't confuse iconic brand-name recognition with business of Nike itself. Turnaround story. Won't trade at the premium it used to. Athletic world is a lot more fragmented. Not a structural long-term hold. Might be a tactical buying opportunity.

PAST TOP PICK
(A Top Pick May 02/25, Up 6%)

Heavy investments in AI took the stock down. He's sees spending not as a weakness, but as a source of strength by leaning into its scale and distribution advantages. Strongly advocates it as a Buy today.

PAST TOP PICK
(A Top Pick May 02/25, Up 33%)

Drop is interesting buying opportunity, if not one that will blow the doors off. Backlog sold out for years, strong margin upside on servicing. Strong trends for years.

PAST TOP PICK
(A Top Pick May 02/25, Down 7%)

Owns, but he's selling out of it for an opportunity in TMO. TMO can control more things in its wheelhouse, whereas DHR has to do deals to fill out its portfolio. Both names have been selling off at the same rate in the past 2 months.

Most popular stocks on Stockchase